At Cellogen Therapeutics, we are proud to house India’s largest Lentivirus Production Facility, purpose-built to support cutting-edge research, translational science, and advanced cell & gene therapy development.
Our facility is designed to deliver high-titer, high-purity lentiviral vectors with consistency, scalability, and stringent quality controls—empowering scientists and institutions to accelerate breakthroughs in genetic engineering, CAR-T development, and functional genomics.
Whether you are in early-stage discovery or advancing toward clinical applications, Cellogen Therapeutics provides the infrastructure, expertise, and reliability you need.
Built for scale, our facility supports high-volume production requirements for both research and pre-clinical needs.
We follow rigorous quality control protocols to ensure high transduction efficiency, purity, and reproducibility.
Backed by a team of experienced scientists specializing in lentiviral systems and genetic engineering.
Our clients include premier CSIR labs and DBT-funded institutes, reflecting our credibility and scientific excellence
From vector design to final delivery, we tailor solutions to meet your exact research and therapeutic requirements.
We are proud to partner with some of India’s most respected research ecosystems, including:
These collaborations underscore our commitment to enabling high-impact science.
Ready to accelerate your research with reliable lentiviral solutions?
Cellogen Therapeutics Pvt. Ltd. Floor-9, Magnus Tower, Sector-73, Noida, UP-201301
